92 related items for PubMed ID: 9283216
21. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K, Hewitson TD, Kincaid-Smith P.
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[Abstract] [Full Text] [Related]
22. [MCNS, which secondary developed into incidental IgA nephropathy--a case report].
Tsunehisa N, Takemura T, Inui T, Kamiya H.
Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1095-9. PubMed ID: 1289609
[Abstract] [Full Text] [Related]
23. [Clinical evaluation of tonsillectomy with modified high-dose intravenous methylprednisolone therapy in patients with IgA nephropathy].
Sugawara K, Takeda K, Nakai K, Takahashi N, Adachi T, Fukuda T, Miura S.
Nihon Jinzo Gakkai Shi; 2008 Oct; 50(8):1017-23. PubMed ID: 19172803
[Abstract] [Full Text] [Related]
24. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
Manno C, Gesualdo L, D'Altri C, Rossini M, Grandaliano G, Schena FP.
J Nephrol; 2001 Oct; 14(4):248-52. PubMed ID: 11506246
[Abstract] [Full Text] [Related]
25. [Study of correlation between urinary IL-6 level and mesangial lesion in childhood onset IgA nephropathy].
Akutsu Y.
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):686-96. PubMed ID: 7959587
[Abstract] [Full Text] [Related]
26. [Clinical study on dan shao tang in treating IgA nephropathy of deficiency of yin with damp-heat symptom].
Wu X, Li J, Liu B.
Zhong Yao Cai; 2003 Nov; 26(11):844-6. PubMed ID: 14989068
[Abstract] [Full Text] [Related]
27. The impact of sex in primary glomerulonephritis.
Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S, Genes, Gender and Glomerulonephritis Group.
Nephrol Dial Transplant; 2008 Jul; 23(7):2247-53. PubMed ID: 18182409
[Abstract] [Full Text] [Related]
28. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases.
Tencer J, Torffvit O, Björnsson S, Thysell H, Grubb A, Rippe B.
Clin Nephrol; 1997 Oct; 48(4):212-9. PubMed ID: 9352154
[Abstract] [Full Text] [Related]
29. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
[Abstract] [Full Text] [Related]
30. The significance of focal and segmental hyalinosis and sclerosis (FSHS) and nephrotic range proteinuria in IgA nephropathy.
Packham DK, Yan HD, Hewitson TD, Nicholls KM, Fairley KF, Kincaid-Smith P, Becker GJ.
Clin Nephrol; 1996 Oct; 46(4):225-9. PubMed ID: 8905206
[Abstract] [Full Text] [Related]
31. Clinicopathologic correlation of C1q nephropathy in children.
Fukuma Y, Hisano S, Segawa Y, Niimi K, Tsuru N, Kaku Y, Hatae K, Kiyoshi Y, Mitsudome A, Iwasaki H.
Am J Kidney Dis; 2006 Mar; 47(3):412-8. PubMed ID: 16490619
[Abstract] [Full Text] [Related]
32. [A case of childhood IgA nephropathy who developed rapidly progressive glomerulonephritis in one-year clinical course].
Motoyama O, Nagai Y, Hasegawa A, Hirata K, Kawamura S, Iitaka K.
Nihon Jinzo Gakkai Shi; 1991 Jun; 33(6):615-21. PubMed ID: 1920941
[Abstract] [Full Text] [Related]
33. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D, Ahuja M, Shortland JR, Brown CB.
Nephrol Dial Transplant; 1995 Jun; 10(7):1173-81. PubMed ID: 7478120
[Abstract] [Full Text] [Related]
34. A case of minimal change nephrotic syndrome with immunoglobulin A nephropathy transitioned to focal segmental glomerulosclerosis.
Hirose M, Nishino T, Uramatsu T, Obata Y, Kitamura M, Kawazu T, Miyazaki M, Taguchi T, Kohno S.
Clin Exp Nephrol; 2012 Jun; 16(3):473-9. PubMed ID: 22258558
[Abstract] [Full Text] [Related]
35. No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria.
Kano K, Nishikura K, Yamada Y, Arisaka O.
Clin Nephrol; 2005 Feb; 63(2):74-9. PubMed ID: 15730048
[Abstract] [Full Text] [Related]
36. Steroid therapy in primary glomerulonephritis.
Davison AM.
Nephrol Dial Transplant; 1990 Feb; 5 Suppl 1():23-8. PubMed ID: 2129454
[No Abstract] [Full Text] [Related]
37. Mycophenolate mofetil in primary glomerulopathies.
Sepe V, Libetta C, Giuliano MG, Adamo G, Dal Canton A.
Kidney Int; 2008 Jan; 73(2):154-62. PubMed ID: 17989649
[Abstract] [Full Text] [Related]
38. [The influence of exercise loading for a long period on the renal function of the children with mesangial proliferative glomerulonephritis].
Furuse A, Ushijima T, Terashima T, Karashima S, Hattori S, Matsuda I.
Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1081-7. PubMed ID: 1808359
[Abstract] [Full Text] [Related]
39. [Prospective, multi-centered, randomized and controlled trial on effect of Shenle Capsule in treating patients with IgA nephropathy of Fei-Pi qi-deficiency syndrome].
Chen XM, Chen YP, Zhou ZL.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Dec; 26(12):1061-5. PubMed ID: 17205814
[Abstract] [Full Text] [Related]
40. Huai Qi Huang ameliorates proteinuria and hematuria in mild IgA nephropathy patients: a prospective randomized controlled study.
Li LT, Shi MY, Wei SY, Li T, Li B.
J Formos Med Assoc; 2013 Dec; 112(12):766-72. PubMed ID: 24280442
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
